Cargando…

Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases

BACKGROUND: Disturbed hepatic energy metabolism contributes to non-alcoholic fatty liver (NAFLD), but the development of changes over time and obesity- or diabetes-related mechanisms remained unclear. METHODS: Two-day old male C57BL/6j mice received streptozotocin (STZ) or placebo (PLC) and then hig...

Descripción completa

Detalles Bibliográficos
Autores principales: Dewidar, Bedair, Mastrototaro, Lucia, Englisch, Cornelia, Ress, Claudia, Granata, Cesare, Rohbeck, Elisabeth, Pesta, Dominik, Heilmann, Geronimo, Wolkersdorfer, Martin, Esposito, Irene, Reina Do Fundo, Michelle, Zivehe, Fariba, Yavas, Aslihan, Roden, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384226/
https://www.ncbi.nlm.nih.gov/pubmed/37454552
http://dx.doi.org/10.1016/j.ebiom.2023.104714
_version_ 1785081105548836864
author Dewidar, Bedair
Mastrototaro, Lucia
Englisch, Cornelia
Ress, Claudia
Granata, Cesare
Rohbeck, Elisabeth
Pesta, Dominik
Heilmann, Geronimo
Wolkersdorfer, Martin
Esposito, Irene
Reina Do Fundo, Michelle
Zivehe, Fariba
Yavas, Aslihan
Roden, Michael
author_facet Dewidar, Bedair
Mastrototaro, Lucia
Englisch, Cornelia
Ress, Claudia
Granata, Cesare
Rohbeck, Elisabeth
Pesta, Dominik
Heilmann, Geronimo
Wolkersdorfer, Martin
Esposito, Irene
Reina Do Fundo, Michelle
Zivehe, Fariba
Yavas, Aslihan
Roden, Michael
author_sort Dewidar, Bedair
collection PubMed
description BACKGROUND: Disturbed hepatic energy metabolism contributes to non-alcoholic fatty liver (NAFLD), but the development of changes over time and obesity- or diabetes-related mechanisms remained unclear. METHODS: Two-day old male C57BL/6j mice received streptozotocin (STZ) or placebo (PLC) and then high-fat (HFD) or regular chow diet (RCD) from week 4 (W4) to either W8 or W16, yielding control [CTRL = PLC + RCD], diabetes [DIAB = STZ + RCD], obesity [OBES = PLC + HFD] and diabetes-related non-alcoholic steatohepatitis [NASH = STZ + HFD] models. Mitochondrial respiration was measured by high-resolution respirometry and insulin-sensitive glucose metabolism by hyperinsulinemic-euglycemic clamps with stable isotope dilution. FINDINGS: NASH showed higher steatosis and NAFLD activity already at W8 and liver fibrosis at W16 (all p < 0.01 vs CTRL). Ballooning was increased in DIAB and NASH at W16 (p < 0.01 vs CTRL). At W16, insulin sensitivity was 47%, 58% and 75% lower in DIAB, NASH and OBES (p < 0.001 vs CTRL). Hepatic uncoupled fatty acid oxidation (FAO)-associated respiration was reduced in OBES at W8, but doubled in DIAB and NASH at W16 (p < 0.01 vs CTRL) and correlated with biomarkers of unfolded protein response (UPR), oxidative stress and hepatic expression of certain enzymes (acetyl-CoA carboxylase 2, Acc2; carnitine palmitoyltransferase I, Cpt1a). Tricarboxylic acid cycle (TCA)-driven respiration was lower in OBES at W8 and doubled in DIAB at W16 (p < 0.0001 vs CTRL), which positively correlated with expression of genes related to lipolysis. INTERPRETATION: Hepatic mitochondria adapt to various metabolic challenges with increasing FAO-driven respiration, which is linked to dysfunctional UPR, systemic oxidative stress, insulin resistance and altered lipid metabolism. In a diabetes model, higher TCA-linked respiration reflected mitochondrial adaptation to greater hepatic lipid turnover. FUNDING: Funding bodies that contributed to this study were listed in the acknowledgements section.
format Online
Article
Text
id pubmed-10384226
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103842262023-07-30 Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases Dewidar, Bedair Mastrototaro, Lucia Englisch, Cornelia Ress, Claudia Granata, Cesare Rohbeck, Elisabeth Pesta, Dominik Heilmann, Geronimo Wolkersdorfer, Martin Esposito, Irene Reina Do Fundo, Michelle Zivehe, Fariba Yavas, Aslihan Roden, Michael eBioMedicine Articles BACKGROUND: Disturbed hepatic energy metabolism contributes to non-alcoholic fatty liver (NAFLD), but the development of changes over time and obesity- or diabetes-related mechanisms remained unclear. METHODS: Two-day old male C57BL/6j mice received streptozotocin (STZ) or placebo (PLC) and then high-fat (HFD) or regular chow diet (RCD) from week 4 (W4) to either W8 or W16, yielding control [CTRL = PLC + RCD], diabetes [DIAB = STZ + RCD], obesity [OBES = PLC + HFD] and diabetes-related non-alcoholic steatohepatitis [NASH = STZ + HFD] models. Mitochondrial respiration was measured by high-resolution respirometry and insulin-sensitive glucose metabolism by hyperinsulinemic-euglycemic clamps with stable isotope dilution. FINDINGS: NASH showed higher steatosis and NAFLD activity already at W8 and liver fibrosis at W16 (all p < 0.01 vs CTRL). Ballooning was increased in DIAB and NASH at W16 (p < 0.01 vs CTRL). At W16, insulin sensitivity was 47%, 58% and 75% lower in DIAB, NASH and OBES (p < 0.001 vs CTRL). Hepatic uncoupled fatty acid oxidation (FAO)-associated respiration was reduced in OBES at W8, but doubled in DIAB and NASH at W16 (p < 0.01 vs CTRL) and correlated with biomarkers of unfolded protein response (UPR), oxidative stress and hepatic expression of certain enzymes (acetyl-CoA carboxylase 2, Acc2; carnitine palmitoyltransferase I, Cpt1a). Tricarboxylic acid cycle (TCA)-driven respiration was lower in OBES at W8 and doubled in DIAB at W16 (p < 0.0001 vs CTRL), which positively correlated with expression of genes related to lipolysis. INTERPRETATION: Hepatic mitochondria adapt to various metabolic challenges with increasing FAO-driven respiration, which is linked to dysfunctional UPR, systemic oxidative stress, insulin resistance and altered lipid metabolism. In a diabetes model, higher TCA-linked respiration reflected mitochondrial adaptation to greater hepatic lipid turnover. FUNDING: Funding bodies that contributed to this study were listed in the acknowledgements section. Elsevier 2023-07-16 /pmc/articles/PMC10384226/ /pubmed/37454552 http://dx.doi.org/10.1016/j.ebiom.2023.104714 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Dewidar, Bedair
Mastrototaro, Lucia
Englisch, Cornelia
Ress, Claudia
Granata, Cesare
Rohbeck, Elisabeth
Pesta, Dominik
Heilmann, Geronimo
Wolkersdorfer, Martin
Esposito, Irene
Reina Do Fundo, Michelle
Zivehe, Fariba
Yavas, Aslihan
Roden, Michael
Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
title Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
title_full Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
title_fullStr Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
title_full_unstemmed Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
title_short Alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
title_sort alterations of hepatic energy metabolism in murine models of obesity, diabetes and fatty liver diseases
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10384226/
https://www.ncbi.nlm.nih.gov/pubmed/37454552
http://dx.doi.org/10.1016/j.ebiom.2023.104714
work_keys_str_mv AT dewidarbedair alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT mastrototarolucia alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT englischcornelia alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT ressclaudia alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT granatacesare alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT rohbeckelisabeth alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT pestadominik alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT heilmanngeronimo alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT wolkersdorfermartin alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT espositoirene alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT reinadofundomichelle alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT zivehefariba alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT yavasaslihan alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases
AT rodenmichael alterationsofhepaticenergymetabolisminmurinemodelsofobesitydiabetesandfattyliverdiseases